[
  {
    "ts": null,
    "headline": "MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease",
    "summary": "The FDA approves Mesoblast's Ryoncil (remestemcel-L) for treating pediatric patients with steroid-refractory acute graft versus host disease. Shares rise.",
    "url": "https://finnhub.io/api/news?id=21d08d8ccfd1bace439cf23a26dcde7732ae0fe736d11214402a314edc10feb3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734632160,
      "headline": "MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease",
      "id": 132057776,
      "image": "https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "The FDA approves Mesoblast's Ryoncil (remestemcel-L) for treating pediatric patients with steroid-refractory acute graft versus host disease. Shares rise.",
      "url": "https://finnhub.io/api/news?id=21d08d8ccfd1bace439cf23a26dcde7732ae0fe736d11214402a314edc10feb3"
    }
  }
]